作者:
Camille,Guillerey [1]
;
Kyohei,Nakamura [2]
;
Andrea C,Pichler [3]
;
Deborah,Barkauskas [1]
;
Sophie,Krumeich [4]
;
Kimberley,Stannard [1]
;
Kim,Miles [1]
;
Heidi,Harjunpää [1]
;
Yuan,Yu [1]
;
Mika,Casey [2]
;
Alina I,Doban [5]
;
Mircea,Lazar [1]
;
Gunter,Hartel [1]
;
David,Smith [6]
;
Slavica,Vuckovic [7]
;
Michele Wl,Teng [8]
;
P Leif,Bergsagel [8]
;
Marta,Chesi [9]
;
Geoffrey R,Hill [10]
;
Ludovic,Martinet [5]
;
Mark J,Smyth [11]
作者单位:
Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
[1]
School of Medicine, The University of Queensland, Herston, Queensland, Australia.
[2]
Cancer Immunotherapies Laboratory, Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
[3]
Cancer Research Center of Toulouse, INSERM UMR 1037, Toulouse, France.
[4]
Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
[5]
ASML Netherlands B.V., Veldhoven, Netherlands.
[6]
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands.
[7]
Statistics Unit and.
[8]
Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
[9]
Multiple Myeloma Research Group, Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
[10]
Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona, USA.
[11]
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
[12]
主题词
4-1BB配体(4-1BB Ligand);动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);抗原, 肿瘤(Antigens, Neoplasm);抗肿瘤药(Antineoplastic Agents);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);疾病模型, 动物(Disease Models, Animal);免疫因子类(Immunologic Factors);免疫疗法(Immunotherapy);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);多发性骨髓瘤(Multiple Myeloma);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory)
DOI
10.1172/jci.insight.125932
PMID
31194697
发布时间
2020-07-20